For more than 50 years, scientists have sought alternatives to silicon for building molecular electronics. The vision was ...
Argenx ($ARGX) announced an update on their ongoing clinical study. Argenx (ARGX) is launching a Phase 2 clinical study evaluating ARGX-119 IV for ...
Asheville is taking the next steps toward designing a physical gateway and "cultural corridor" between Pack Square and The ...
Administrators can elevate special education teams from support roles to central drivers of inclusive instruction.
Christmas traditions such as decorating a tree and singing not only lift spirits but also boost immunity by triggering immune ...
The study identifies structural weaknesses that could undermine the role of AI as a sustainability accelerator. One of the ...
Tiny molecules that can think, remember, and learn may be the missing link between electronics and the brain. For more than ...
Holly Cummins gave a keynote at Goto Copenhagen where she urged developers to care about overlooked issues that shape their ...
Bun 1.3 revolutionizes full-stack JavaScript development with unified database APIs and zero-config frontend setup.
Morocco’s Ministry of Equipment and Water launched a new study to design an upgraded flood protection system for the coastal city of Safi ...
TipRanks on MSN
Astellas completes key menopause drug study in Japan, setting up next growth phase for fezolinetant
Astellas Pharma ($ALPMF) announced an update on their ongoing clinical study. Study Overview Astellas Pharma is running a late-stage study called ...
HealthDay on MSN
SABCS: Risk-Based Screening Noninferior for Identifying Stage IIB or Higher Breast Cancer
Risk-based screening is noninferior to annual screening for detecting stage ≥IIB cancers, does not reduce biopsy rates despite fewer mammograms.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results